Abstract: The method of the present invention provides a means for protecting a patient, including a transplant patient, from reperfusion injury by administering CM101 or GBS toxin isolated from Group B &bgr;-hemolytic Streptococcus bacteria. The present invention also includes a method to protect a tissue or organ against reperfusion injury in a transplant patient.
Type:
Grant
Filed:
July 29, 1999
Date of Patent:
December 30, 2003
Assignees:
Yeda Reaearch and Development Co., Ltd., Vanderbilt University
Inventors:
Carl G. Hellerqvist, Michal Neeman, Barbara D. Wamil, Rinat Abramovitch